ONCBeOne Medicines
+5.1% today · +22.4% over a year
7/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 93% of the instruments we score
Quality, Stability: among the best of its peers; priced lower than most peers. No dividend.
BeOne Medicines (ONC) valuation against sector peers: P/E 50.8 (sector median 29.2), P/B 8.0, EV/EBIT 35.3, free-cash-flow yield 3.1%, P/S 7.0.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | ONC | Sector median | vs median |
|---|---|---|---|
| P/E | 50.8 | 29.2 · n=157 | 74% above |
| P/B | 8.0 | 3.8 · n=307 | 109% above |
| P/S | 7.0 | 4.1 · n=300 | 72% above |
| EV/EBIT | 35.3 | 25.6 · n=145 | 38% above |
| Free-cash-flow yield | 3.1% | 1.5% · n=289 | 111% above |
| Dividend yield | 0.00% | 0.00% · n=362 | — |
| Return on equity | 18.4% | −2.4% · n=306 | — |
| Return on invested capital | 97.8% | 0.6% · n=280 | 15,072% above |
| Gross margin | 89.4% | 63.3% · n=205 | 41% above |
| Net debt / EBITDA | −3.62 | 1.30 · n=150 | 379% below |
Value factor: 60 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 46.2 | 31.6 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 41.3 | 8.2 | — | 3.1% | 1.9% | 8/10 |
| ABBVAbbVie | 50.0 | — | 27.6 | 3.7% | 2.9% | 6/10 |
| MRKMerck | 147.5 | 8.1 | — | 4.1% | 2.3% | 8/10 |
| UNHUnitedHealth | 22.2 | 3.4 | 16.9 | 6.5% | 2.3% | 10/10 |
| TMOThermo Fisher Scientific | 36.4 | 4.7 | 34.5 | 3.0% | 0.3% | 9/10 |
| AMGNAmgen | 26.5 | 17.4 | 23.0 | 3.8% | 2.2% | 8/10 |
| GILDGilead Sciences | — | 15.9 | — | 6.7% | 1.9% | 4/10 |
| ABTAbbott | 40.5 | 3.7 | 32.8 | 3.5% | 2.8% | 6/10 |
| PFEPfizer | 41.5 | 1.9 | — | 7.0% | 7.3% | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 05 Nov 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.